Please login to the form below

Not currently logged in
Email:
Password:

The Royal Marsden

This page shows the latest The Royal Marsden news and features for those working in and with pharma, biotech and healthcare.

Call for genetic tests to bring personalised medicine to children with cancer

Call for genetic tests to bring personalised medicine to children with cancer

Experts at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust want the NHS to dramatically scale up access to genetic sequencing for children, so that doctors ... Professor Louis Chesler. Professor Louis Chesler,

Latest news

  • Innovating patient care Innovating patient care

    His institution is also part of a vanguard project with London hospitals the Royal Marsden and UCLH. ... The savings associated run into hundreds of millions of pounds. If we get it right between the Christie, the Royal Marsden and UCLH, it will

  • BMS launches Opdivo for lung cancer in UK BMS launches Opdivo for lung cancer in UK

    Commenting on the launch for lung cancer, Dr Sanjay Popat of the Royal Marsden hospital said: "This group of patients with relapsed squamous-type lung cancer represents a considerable unmet medical ... need in the UK, as chemotherapy has been their main

  • NHS sponsors charity on metastatic breast cancer study NHS sponsors charity on metastatic breast cancer study

    With funding from Walk the Walk and sponsorship by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research (ICR), London, the LEGACY study allows patients with secondary breast ... Peter Barry, consultant oncoplastic breast surgeon at

  • Personalised cancer medicines showcased in BBC investigation Personalised cancer medicines showcased in BBC investigation

    efficacy. In the Panorama investigation, the editorial team spent two years filming at the Royal Marsden Hospital and its Institute of Cancer Research arm in London, and followed a number of ... Doctors at the Royal Marsden used Novartis' Zykadia

  • Boehringer's oncology unit scores first EU approval Boehringer's oncology unit scores first EU approval

    cancers associated with a high mortality such as lung cancer", said Dr Sanjay Popat of the Royal Marsden NHS Foundation Trust in the UK, and lead investigator in Giotrif's pivotal ... Boehringer has plans to extend the indications for Giotrif into breast

More from news
Approximately 1 fully matching, plus 19 partially matching documents found.

Latest from PMHub

  • Why is the UK lagging behind the rest of Europe in cancer survival?

    Say Communications, London healthcare PR agency, discusses the latest technologies that will improve cancer survival rates in UK. ... Research  on prostate, lung and bowel cancer tests are under way at the Royal Marsden and a similar blood test has

  • Leading the conversation in oncology

    We have fostered unique working partnerships with organisations such as The Royal Marsden Hospital and e cancer, Europe’s leading oncology channel, and are proud of our long-standing role as ... The Royal Marsden Hospital NHS Foundation Trust, London.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics